AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 86 filers reported holding AVROBIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $734,000 | +142.2% | 36,483 | +95.7% | 0.09% | +309.5% |
Q2 2019 | $303,000 | -63.8% | 18,644 | -50.9% | 0.02% | -46.2% |
Q1 2019 | $837,000 | +152.9% | 38,000 | +91.0% | 0.04% | +69.6% |
Q4 2018 | $331,000 | -34.8% | 19,900 | +103.1% | 0.02% | -20.7% |
Q3 2018 | $508,000 | – | 9,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
Western Standard LLC | 310,361 | $477,956 | 0.43% |
Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |